Aby Buchbinder

2013

In 2013, Aby Buchbinder earned a total compensation of $515.1K as Former Vice President, Clinical Development at Enzon Pharmaceuticals, a 12% decrease compared to previous year.

Compensation breakdown

Salary$91,044
Other$424,081
Total$515,125

Buchbinder received $424.1K in other compensation, accounting for 82% of the total pay in 2013.

Buchbinder also received $91K in salary.

Rankings

In 2013, Aby Buchbinder's compensation ranked 9,263rd out of 12,286 executives tracked by ExecPay. In other words, Buchbinder earned more than 24.6% of executives.

ClassificationRankingPercentile
All
9,263
out of 12,286
25th
Division
Manufacturing
3,390
out of 4,612
27th
Major group
Chemicals And Allied Products
1,073
out of 1,462
27th
Industry group
Drugs
824
out of 1,156
29th
Industry
Biological Products, Except Diagnostic Substances
135
out of 196
31st
Source: SEC filing on April 16, 2014.

Buchbinder's colleagues

We found five more compensation records of executives who worked with Aby Buchbinder at Enzon Pharmaceuticals in 2013.

2013

Andrew Rackear

Enzon Pharmaceuticals

General Counsel

2013

Charles Conover

Enzon Pharmaceuticals

Former Senior Vice President of Research & Development, Program Management

2013

George Hebard

Enzon Pharmaceuticals

Chief Operating Officer

2013

Timothy Daly

Enzon Pharmaceuticals

Chief Accounting Officer

2013

Richard Feinstein

Enzon Pharmaceuticals

Vice President Finance and Principal Financial Officer

You may also like